ACETライブシグナル | Getagraph.comで利益を最大化

買う 107760 min ago

@ $2.93

発行日: 15 2月 2024 @ 05:42

リターン: -42.56%

前回のシグナル: 2月 15 - 04:49

前回のシグナル: 売る

リターン: -1.02 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:43):

Stats
本日の出来高	348 575
平均出来高	1.30M
時価総額	138.04M
EPS	$-0.690 ( 2024-03-20 )
次の収益日	( $-0.350 ) 2024-05-14
Last Dividend	$0.0100 ( 2018-09-21 )
Next Dividend	$0 ( N/A )
P/E	-0.510
ATR14	$0.00600 (0.36%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-25	Orbimed Advisors Llc	Buy	1 841 100	Common Stock
2024-01-25	Orbimed Advisors Llc	Buy	1 041 700	Common Stock
2024-01-25	Orbimed Advisors Llc	Buy	242 200	Common Stock
2024-01-25	Gordon Carl L	Buy	1 841 100	Common Stock
2024-01-25	Gordon Carl L	Buy	1 041 700	Common Stock

INSIDER POWER
58.29
Last 100 transactions
Buy: 13 014 935 \| Sell: 4 163 691

ボリューム相関

長: 0.03 (neutral)

短: 0.26 (neutral)

Signal:(50.607) Neutral

Aceto Corporation 相関

10 最も正の相関
FGEN	0.968
ALLR	0.967
JBLU	0.965
RIDE	0.954
GSIT	0.953
TSVT	0.953
AIHS	0.952
ELEV	0.95
SEED	0.95
PPBT	0.95

10 最も負の相関
HCKT	-0.963
XP	-0.961
NEOG	-0.96
VERA	-0.96
NCAC	-0.958
MSDA	-0.957
APEN	-0.957
BRIVU	-0.956
AGNCO	-0.955
MITA	-0.954

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Aceto Corporation 相関 - 通貨/商品

0.00
( neutral )

0.39
( neutral )

0.00
( neutral )

0.39
( neutral )

Aceto Corporation 財務諸表

Annual	2023
収益:	$0
総利益:	$-6.10M (0.00 %)
EPS:	$-3.31

FY	2023
収益:	$0
総利益:	$-6.10M (0.00 %)
EPS:	$-3.31

FY	2022
収益:	$24.99M
総利益:	$19.98M (79.96 %)
EPS:	$-1.630

FY	2021
収益:	$9.73M
総利益:	$9.73M (100.00 %)
EPS:	$-2.00

Financial Reports:

No articles found.

Aceto Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Aceto Corporation Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.100	2009-06-11
Last Dividend	$0.0100	2018-09-21
Next Dividend	$0	N/A
Payout Date	2018-10-09
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	$2.12	--
Avg. Dividend % Per Year	0.00%	--
Score	1.82	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-08-01)

$0 Estimate 0.00 %

Dividend Stability

0.11 Bad

Dividend Score

1.82

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0.0850	0.75%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.682	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-1.689	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	8.41	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.28	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	8.28	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.101	-1.500	8.32	-10.00	[0 - 0.6]
interestCoverageTTM	-6 335.00	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-2.18	2.00	-0.726	-1.452	[0 - 30]
freeCashFlowPerShareTTM	-2.28	2.00	-1.141	-2.28	[0 - 20]
debtEquityRatioTTM	0.123	-1.500	9.51	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-4.48	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.673

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.511	1.000	-0.153	0	[1 - 100]
returnOnEquityTTM	-1.689	2.50	-10.00	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.28	2.00	-0.760	-2.28	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-2.18	2.00	-0.726	-1.452	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0202	1.500	-3.47	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-2.08

Aceto Corporation

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.